Lupin inks pact with China’s Sino Universal for Tiotropium inhaler supply
Global pharmaceutical major Lupin Limited (Lupin) on June 16, 2025, announced a significant move to expand its presence…
Lupin’s USA facility gets 6 USFDA observations
The Pre-approval inspection was conducted from 7 May 2024 to 17 May 2024, and closed with an issuance…
Lupin’s COVID-19 drug Molnupiravir launched in India
The Medicine Controller General of India (DCGI) has issued the drug emergency use authorization for the treatment of…